|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08247 BIOSINO BIO-TEC
Nominal 
0.800 0.000 (0.000%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 289,073 | -22.515% | 373,071 | 348,225 | 325,256 | 397,408 |
| Cost of Sales | (161,708) | -28.698% | (226,794) | (204,633) | (214,695) | (229,005) |
| Gross Profit | 127,365 | -12.929% | 146,277 | 143,592 | 110,561 | 168,403 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (712) | 267.010% | (194) | (129) | 5,417 | (144,134) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 12,346 | 88.950% | 6,534 | 1,573 | 2,130 | 4,753 | |
| Profit / (Loss) before Taxation | (17,613) | -- | 18,516 | 6,407 | 2,155 | (114,807) | |
| Taxation | (1,628) | -62.262% | (4,314) | (3,247) | (2,861) | (3,636) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 7,593 | -- | (6,096) | (4,300) | 3,424 | 8,030 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (11,648) | -- | 8,106 | (1,140) | 2,718 | (110,413) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 6,072 | -6.325% | 6,482 | 10,346 | 412 | 19,848 |
| Depreciation & Amortisation | 20,357 | -16.326% | 24,329 | 27,928 | 25,293 | 33,412 |
| Directors' Emoluments | 3,819 | 79.972% | 2,122 | 2,522 | 1,852 | 2,433 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -8.000 | -- | 5.600 | -0.800 | 1.900 | -76.300 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.045) | -- | 0.308 | 0.338 | 0.079 | 0.217 |
| NBV per share ($) | 1.454 | -- | 1.423 | 1.217 | 1.225 | 1.208 |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -13,182,000 |
| %Change | 143.076% |
| EPS / (LPS) | RMB -0.091 |
| NBV Per Share (¥) | RMB 1.363 |